View Cart

Cardiovascular Health

Metabolic Cardiology: Solving the Heart’s Energy Crisis

By Erik L. Goldman | Editor-in-Chief - Vol. 9, No. 2. , 2008

A new vanguard of “metabolic” cardiologists contends that cholesterol elevation has been overstated as a cause of heart disease, and that physicians should pay more attention to the heart muscle itself. A quartet of nutrients magnesium, co-enzyme Q10, L-carnitine, and D-ribose can profoundly improve the heart’s pumping ability and reduce risk of death, even in very ill patients.

Read more ...

HPC Readers Boost TACT Trial Enrollment

By Staff Writer - Vol. 9, No. 2. , 2008

Readers of Holistic Primary Care are giving a big boost to the Trial to Assess Chelation Therapy (TACT), a landmark NIH study to determine whether chelation therapy can prevent heart attacks. After reading about the ongoing trial in our Spring 2008 edition, 17 physician readers called the study’s headquarters in Miami Beach, seeking to enroll their clinics as study sites.

Read more ...

“Bad Cholesterol”: Good Marketing, But Is It Good Medicine?

By Cleaves M. Bennett, MD | Contributing Writer - Vol. 8, No. 3. , 2007

The cholesterol model of heart disease, which labels LDL as “bad” and HDL as “good,” has certainly helped drug companies sell a lot of statin medications. But has it really reduced the impact of obesity, heart disease and diabetes in this country? “Not really,” says Dr. Cleaves Bennett, one of the nation’s leading experts on hypertension, kidney disease and preventive medicine.

Read more ...

Does C-reactive Protein Have a Place in the CVD Risk Pantheon?

By Michael Traub, ND - Vol. 8, No. 1. , 2007

One of the hottest debates in cardiology for the past few years centers on the question of whether C-reactive protein is a meaningful risk indicator for heart disease. It clearly correlates with a tendency toward inflammation, but is it truly causative? Dr. Traub contends that even if there’s no direct causal relationship, an elevated CRP is telling you that something’s wrong—something that warrants attention.

Read more ...

In the Thick of It: Blood Viscosity Emerges as Key Heart Risk Factor

By August West | Contributing Writer - Vol. 8, No. 1. , 2007

Blood viscosity, the actual thickness of a person’s blood, is emerging as an important risk factor for heart disease: thicker blood means higher risk. New technology will soon enable doctors to measure viscosity routinely. Best of all, an enzyme derived from the Japanese soy food called natto, can effectively lower blood viscosity with minimal risk of side effects.

Read more ...

Rethinking Hyperlipidemia and Natural Treatment Options for Women at Risk

By Tori Hudson, ND | Contributing Writer - Vol. 7, No. 3. , 2006

A recent metanalysis is challenging the notion that soy protein and soy isoflavones can improve women’s cholesterol profiles. But the study did not account for the fact that some women convert soy isoflavones into equol, a powerful phytoestrogen, while others do not. In a separate study, German researchers found that policosanol, a sugar cane derived substance, had no meaningful effect on lipid profiles or cardiovascular risk.

Read more ...

Obesity: WAT’s Up With That?

By Erik Goldman | Editor in Chief - Vol. 7, No. 2. , 2006

White Adipose Tissue (WAT), the raw material of love handles, secretes a wide range of signaling substances that can radically change metabolism. Dr. Jay Udani reviews the new science emerging on this topic, and explains why it becomes progressively more difficult for obese people to lose weight, even when they try very hard.

Read more ...

Copyright © 2025 Holistic Primary Care. All Rights Reserved.